- Home
- TOP vs DYAI Comparison
TOP vs DYAI Comparison
Compare TOP & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TOP | DYAI |
|---|---|---|
| Founded | 2015 | 1979 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.3M | 30.8M |
| IPO Year | 2021 | 2003 |
Fundamental Metrics
Financial Performance| Metric | TOP | DYAI |
|---|---|---|
| Price | $0.90 | $0.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 28.3K | ★ 68.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,495,389.00 |
| Revenue This Year | N/A | $12.52 |
| Revenue Next Year | N/A | $92.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 20.58 |
| 52 Week Low | $0.94 | $0.71 |
| 52 Week High | $3.33 | $1.47 |
Technical Indicators
Market Signals| Indicator | TOP | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 25.48 | 48.19 |
| Support Level | N/A | $0.73 |
| Resistance Level | $1.13 | $0.87 |
| Average True Range (ATR) | 0.03 | 0.07 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 0.07 | 51.85 |
Price Performance
Historical ComparisonAbout TOP TOP Financial Group Limited
TOP Financial Group Ltd is an online brokerage firm in Hong Kong specializing in trading local and overseas equities, futures, and options products. The Company generates brokerage commission income by enabling its customers to trade on multiple exchanges present globally. The company operates in only one segment which is the futures brokerage service.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.